Sign in

CIK 0000879169

  • Large accelerated filer

INCYTE CORP

Sign in to watch
Ticker
INCY
Exchange
Nasdaq
Industry
Services-Commercial Physical & Biological Research
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943136539
Phone
+1 302-498-6700
Business address
1801 AUGUSTINE CUT-OFF, WILMINGTON, DE, 19803
Former names
INCYTE INC, INCYTE GENOMICS INC, INCYTE PHARMACEUTICALS INC
  1. 4 Grant or award Director acquired 984 shares (grant or award)
  2. 4 Grant or award Director acquired 361 shares (grant or award)
  3. 4 Grant or award Director acquired 367 shares (grant or award)
  4. 4 Grant or award EVP, Head of US Oncology acquired 27,812 shares (grant or award)
  5. 4 Grant or award Chief Executive Officer acquired 36,101 shares (grant or award)
  6. 4 Derivatives Options or other derivatives
  7. 3 Insider Initial Statement of Ownership
  8. 4 Grant or award Special Advisor to the CEO acquired 6,016 shares (grant or award)
  9. 4 Grant or award Director acquired 2,518 shares (grant or award)
  10. 4 Grant or award Director acquired 2,518 shares (grant or award)
  11. 4 Grant or award Director acquired 2,518 shares (grant or award)
  12. 4 Grant or award Director acquired 2,518 shares (grant or award)
  13. 4 Grant or award Director acquired 5,036 shares (grant or award)
  14. 4 Grant or award Director acquired 2,518 shares (grant or award)
  15. 4 Shares withheld for taxes Director gave up 849 shares (to pay taxes)
  16. 4 Grant or award Director acquired 2,518 shares (grant or award)
  17. 4 Planned sale EVP & General Counsel sold 1,795 shares at $68.00 ($122,060)
  18. 4 Planned sale Principal Accounting Officer sold 1,614 shares at an average $65.38 ($105,516)
  19. 4 Grant or award EVP & General Manager US acquired 26,135 shares (grant or award)
  20. 4 Grant or award EVP, GMAPPS acquired 22,141 shares (grant or award)

Page 8 of 82 · 1,628 filings